<DOC>
	<DOCNO>NCT00284856</DOCNO>
	<brief_summary>This multicenter study evaluate efficacy safety MK0476 versus placebo participant chronic asthma actively smoke cigarette .</brief_summary>
	<brief_title>Montelukast Asthmatic Smoker Study ( 0476-332 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Participants chronic asthma actively smoke least 0.5 2 pack cigarette day Participant diagnosis Chronic Obstructive Pulmonary Disease ( COPD ) emphysema .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>